Abstract
Background Non-small-cell lung cancer (NSCLC) accounts for most new diagnoses of lung cancer, with high morbidity and mortality worldwide. Immune chec......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
